CLINICAL_TRIALS trial_result · 2025-04-23

Clinical Trial Update: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease [Phase 3]

A Phase 3 trial evaluating aducanumab in early Alzheimer's disease was terminated and results were posted on 2025-04-23.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Biogen | Conditions: Alzheimer's Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-04-23